Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 March 2023 | Story Nonsindiso Qwabe | Photo Stephen Collett
Prof Francis Petersen_ UFS Official Opening 2023
Prof Francis Petersen outlined the strategic intent of Vision 130 during his official welcoming address.

The trajectory to 2034, when the university turns 130, is not a dream, but an exciting journey that we are working towards achieving. Painting a picture of the university of the future, UFS Rector and Vice-Chancellor, Prof Francis Petersen, welcomed staff in his official opening speech on the Bloemfontein Campus on Friday 17 February 2023.

2023 marks the starting point of Vision 130, a vision with bold ambitions that will lead us to the renewal, re-imagining, and repositioning of the UFS in 2034, Prof Petersen said.  “We are building on our strengths, achievements, and learnings of our past and, in particular, the past five years. The vision is driven by excellence, and we won’t compromise excellence. It is about excellence, but it is also about visibility as an institution, and it is about impact.”

What does the UFS look like in 2034?

Prof Petersen said ours will be a university of choice for exceptional students, exceptional academics, and exceptional support staff. We will be recognised and acknowledged by peers and society as a top-tier university in South Africa, specifically among the top five universities in South Africa and the top 600 globally.

“Remember, I said we have built on the past, specifically the past five years, to give us a foundation. Still, we need to use that foundation to be able to deliver those specific goals or activities or deliverables that we want to achieve. We will have to start now if we want to achieve this in 2034.”

The Rector outlined four goals towards achieving these commitments:

• Improving academic excellence, improving our reputation, and improving our impact.

• Promoting an environment of agility, flexibility, and responsiveness.

• Advancing a transformational institutional culture that demonstrates the values of the University of the Free State – a place where ideas are discussed, contested, improved, and implemented in a culture of civil, robust engagement.

• Promoting stewardship and the prioritisation of institutional resources for strategic intent, which include our people, our staff, and our students.

Understand how your space is connected to Vision 130

“This is about creating a culture of delivery and empowering everyone within the University of the Free State and the UFS community to contribute to the realisation of Vision 130. This is what I am asking of you within your own sphere of operation. I am asking for a renewed commitment from you to own that space that you operate in. To understand how your space is connected to Vision 130 and to share what I would call an unrelenting ambition to deliver on this vision.”

Watch recording of the 2023 Official Opening below:


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept